AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- CHICAGO -- Adding encorafenib (Braftovi) and cetuximab (Erbitux) to FOLFIRI chemotherapy significantly improved progression-free survival (PFS) as first-line treatment of BRAF V600E-mutated metastatic colorectal cancer, according...
Source
MedPage Today
Opens original article in a new tab
(MedPage Today) -- CMS issued an interim final rule Monday outlining implementation rules for new Medicaid work requirements, and health organizations seemed none too happy with it. "Most adults covered by Medicaid are already working, caregiving...
(MedPage Today) -- CHICAGO -- Combining standard transarterial chemoembolization (TACE) with the immunotherapy-based STRIDE regimen improved progression-free survival (PFS) in patients with unresectable hepatocellular carcinoma (HCC), the phase...
(MedPage Today) -- Buffalo Wild Wings now offers an unusual new drink: "Espresso Proteini." Marketed for National Espresso Martini Day, the $12 drink includes 10 grams of Muscle Milk protein powder with a signature Buffalo dry rub rim. While the...
(MedPage Today) -- CHICAGO -- Triple oral metronomic chemotherapy combined with ultra-low-dose immunotherapy (TMC-I) may be a promising first-line treatment for patients in low-resource countries with recurrent or metastatic head and neck squamous...
